These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 12688030

  • 1. [The first oral thrombin inhibitor. Competition to heparins and marcumar?].
    MMW Fortschr Med; 2003 Mar 06; 145(10):56. PubMed ID: 12688030
    [No Abstract] [Full Text] [Related]

  • 2. [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?].
    Nielsen JD.
    Ugeskr Laeger; 2005 May 23; 167(21):2261-5. PubMed ID: 15962850
    [No Abstract] [Full Text] [Related]

  • 3. Low-molecular weight heparins.
    Talley JD.
    J Ark Med Soc; 1997 Apr 23; 93(11):555-6. PubMed ID: 9114648
    [No Abstract] [Full Text] [Related]

  • 4. [New anticoagulants -- their clinical significance].
    Haas S.
    Ther Umsch; 2003 Jan 23; 60(1):19-23. PubMed ID: 12638473
    [Abstract] [Full Text] [Related]

  • 5. [Novel possibilities of antithrombotic therapy in patients with chronic heart failure].
    Ol'binskaia LI, Kolosova KIu, Nesterova SG, Egorova TD, Fedorova AIu.
    Kardiologiia; 2005 Jan 23; 45(12):93-8. PubMed ID: 16353054
    [Abstract] [Full Text] [Related]

  • 6. [Ximelagatran, an oral thrombin inhibitor without the need for regular monitoring of the anticoagulant status].
    Tieleman RG.
    Ned Tijdschr Geneeskd; 2003 Oct 18; 147(42):2046-8. PubMed ID: 14606349
    [Abstract] [Full Text] [Related]

  • 7. The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma.
    Boström SL, Hansson GF, Sarich TC, Wolzt M.
    Thromb Res; 2004 Oct 18; 113(1):85-91. PubMed ID: 15081569
    [Abstract] [Full Text] [Related]

  • 8. [Ximelagatran/Melagatran. Perspectives for new oral antithrombin drugs].
    Samama MM.
    J Mal Vasc; 2004 May 18; 29(2):61-2. PubMed ID: 15229400
    [No Abstract] [Full Text] [Related]

  • 9. Orally active direct thrombin inhibitors.
    Weitz J.
    Semin Vasc Med; 2003 May 18; 3(2):131-8. PubMed ID: 15199476
    [Abstract] [Full Text] [Related]

  • 10. Antithrombotic therapy in atrial fibrillation: ximelagatran, an oral direct thrombin inhibitor.
    Halperin JL.
    Expert Rev Cardiovasc Ther; 2004 Mar 18; 2(2):163-74. PubMed ID: 15151465
    [Abstract] [Full Text] [Related]

  • 11. The therapeutic potential of ximelagatran to become the anticoagulant of choice in medicine: a review of recently completed clinical trials.
    Salam AM, Al-Mousa EN.
    Expert Opin Pharmacother; 2004 Jun 18; 5(6):1423-30. PubMed ID: 15163285
    [Abstract] [Full Text] [Related]

  • 12. Safety and efficacy of enoxaparin compared with unfractionated heparin and oral anticoagulants for prevention of thromboembolic complications in cardioversion of nonvalvular atrial fibrillation: the Anticoagulation in Cardioversion using Enoxaparin (ACE) trial.
    Stellbrink C, Nixdorff U, Hofmann T, Lehmacher W, Daniel WG, Hanrath P, Geller C, Mügge A, Sehnert W, Schmidt-Lucke C, Schmidt-Lucke JA, ACE (Anticoagulation in Cardioversion using Enoxaparin) Study Group.
    Circulation; 2004 Mar 02; 109(8):997-1003. PubMed ID: 14967716
    [Abstract] [Full Text] [Related]

  • 13. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
    MMW Fortschr Med; 2006 Jun 08; 148(23):58-9. PubMed ID: 16826742
    [No Abstract] [Full Text] [Related]

  • 14. [The new antithrombotic agents].
    Meyer Samama M.
    Presse Med; 2005 Oct 22; 34(18):1309-14. PubMed ID: 16269995
    [Abstract] [Full Text] [Related]

  • 15. Mechanism of action of the oral direct thrombin inhibitor ximelagatran.
    Mattsson C, Sarich TC, Carlsson SC.
    Semin Vasc Med; 2005 Aug 22; 5(3):235-44. PubMed ID: 16123910
    [Abstract] [Full Text] [Related]

  • 16. The oral direct thrombin inhibitor, ximelagatran, an alternative for anticoagulant treatment during the puerperium and lactation.
    Hellgren M, Johansson S, Eriksson UG, Wåhlander K.
    BJOG; 2005 May 22; 112(5):579-83. PubMed ID: 15842280
    [Abstract] [Full Text] [Related]

  • 17. Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery.
    Andersen JC.
    Semin Thromb Hemost; 2004 Dec 22; 30(6):609-18. PubMed ID: 15630666
    [Abstract] [Full Text] [Related]

  • 18. Ximelagatran: a novel oral direct thrombin inhibitor for long-term anticoagulation.
    McCullough PA, Dorrell KA, Sandberg KR, Yerkey MW.
    Rev Cardiovasc Med; 2004 Dec 22; 5(2):99-103. PubMed ID: 15184843
    [Abstract] [Full Text] [Related]

  • 19. Ximelagatran, a new oral direct thrombin inhibitor, for the prevention of venous thromboembolic events in major elective orthopaedic surgery. Efficacy, safety and anaesthetic considerations.
    Rosencher N.
    Anaesthesia; 2004 Aug 22; 59(8):803-10. PubMed ID: 15270973
    [Abstract] [Full Text] [Related]

  • 20. Melagatran and ximelagatran: new drug. No real simplification of anticoagulant therapy.
    Prescrire Int; 2005 Aug 22; 14(78):127-32. PubMed ID: 16106594
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.